Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Assistance Publique - HĂ´pitaux de Paris
AbbVie
Diakonhjemmet Hospital
Virtual Tribunal Monastery
University of Aarhus
University of Pittsburgh
Zimmer Biomet
Bristol-Myers Squibb
Bristol-Myers Squibb
Brigham and Women's Hospital
Assistance Publique - HĂ´pitaux de Paris
M.D. Anderson Cancer Center
Emory University
ProgenaBiome
Universitätsklinikum Hamburg-Eppendorf
Universitaire Ziekenhuizen KU Leuven
Pfizer
Instituto Mexicano del Seguro Social